InSpectra St0

Hutchinson Technologies

Advanced StO2 Education Program (ASTEP) - Minneapolis, Minnesota

The Radisson University Hotel



October 15, 2010 - Nurse and RT Program


October 16, 2010 - Physician Program


Learn How InSpectraTM StO2 Monitoring

Offers potential to:

 Assist with responsive assessment of tissue perfusion to manage all patients at risk for circulatory dysfunction.

 Improve management of sepsis and assist in detecting and treating occult hypoperfusion.1

 Monitor tissue perfusion response to vasopressors and inotropes dosing.2

 Help in reducing ICU days.3

 Aid in assuring stable ER/ICU transfers.4



Greg Beilman, MD
"StO2 reflects the severity of illness and resuscitation status in acutely ill patients and predicts poor outcome." 
 
Greg Beilman, MD







REFERENCES:
1Leone M, et al. Anesthesiology. 2009;111:366-371.
2Georger JF, et al. Int Care Med. 2007;33(Supp 2):S166.
3Haas B, et al. AAST 66th Annual Meeting; September 27-29, 2007; Las Vegas,
  NV.
4Kierzek G, et al. Int Care Med. 2008;34(Supp 1):S22. Abstract 0069.

Clinical Evidence

 FAQs

 Bibliography


Case Studies

 Uncontrolled bleeding

 Blunt trauma resuscitation

 Resuscitation

 Patient with persistent hemorrhage

 Coagulopathic trauma patient

 Resuscitation of geriatric patient


Resources

 Watch a demonstration of the
  InSpectra StO2 Tissue 
  Oxygenation Monitor

 Guidelines for Use

 

InSpect our New Product in Development

 


The InSpectraTM StO2 Spot Check
(model 300) is being developed to:
 
- Aid in quickly assessing
tissue perfusion
 
- Help in identifying sick
patients

The Perfect Partner to the
InSpectraTM StO2 Tissue Oxygenation
Monitor (model 650).

InSpectraTM StO2 Spot Check
not for sale. Product in development.